The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
It is worth adding that Versalab is probably a testing solution and Promate something like Exsig Mag.
Rationale: https://twitter.com/CarlosLpzC/status/1321027862984560643
I agree that antigen is much more important but pretty sure it is an antibody one. Here is my rationale: https://twitter.com/MicrogenBioProd/status/1321099964844564481
As I said before:
I am pretty certain it is a Rapid Antibody Test (not ELISA) like UK-RTC AbC-19™ Rapid test from ODX. Maybe for non professional use https://twitter.com/CarlosLpzC/status/1321395513346957314
It is Jersey, UK. There is only 1 airport, he is confused.
https://www.opencell.bio/news/jersey
I am pretty certain it is a Rapid Antibody Test (not ELISA) like UK-RTC AbC-19™ Rapid test from ODX. Maybe for non professional use https://twitter.com/CarlosLpzC/status/1321395513346957314
These are the numbers of one of them, the first one for example: The PathFlow® Strep A
https://microgenbioproducts.com/pathflow-2/#1568996032999-48073c5b-5840
Relative sensitivity: 95.1% (95%CI*: 89.6%~98.2%);
Relative specificity: 97.8% (95%CI*: 95.8%~99%);
Accuracy: 97.1% (95%CI*: 95.3%~98.4%).
They look very good but these are not the same as clinical validation is it?
Although, if it is true, how come Novacyt would be the first to have a LFT with this S/S much higher than any competition?
https://live.euronext.com/en/product/equities/FR0010397232-XPAR -13.66%